General Information of Drug (ID:
DR1773) |
Drug Name |
Clofarabine
|
Synonyms |
Clofarabine; Clofarex; Clolar; Evoltra; clofarabina; clofarabinum; (2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol; (2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol; 123318-82-1; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine; 762RDY0Y2H; C1-F-Ara-A; CAFdA; CHEBI:681569; MFCD00871077; UNII-762RDY0Y2H
|
Indication |
Acute lymphoblastic leukemia
[ICD11: 2B33]
|
Approved
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
303.68 |
Topological Polar Surface Area |
119 |
Heavy Atom Count |
20 |
Rotatable Bond Count |
2 |
Hydrogen Bond Donor Count |
3 |
Hydrogen Bond Acceptor Count |
8 |
Cross-matching ID |
- PubChem CID
- 119182
- PubChem SID
-
8149071
; 10238376
; 10317422
; 12014412
; 14800615
; 14800616
; 29300120
; 46504968
; 47205855
; 50027432
; 56459308
; 57339361
; 71821361
; 77716344
; 81092867
; 92309003
; 92719465
; 93608050
; 99437031
; 99444025
; 103707445
; 104407717
; 109610765
; 118048878
; 124757091
; 125163895
; 126584329
; 126620778
; 126652234
; 126671067
; 129564367
; 134223319
; 134338128
; 135073562
; 135698306
; 136920392
; 136946661
; 136949087
; 137005624
; 141857409
; 143493352
; 144115841
; 144205735
; 152058774
; 152237732
; 152258941
; 160647786
; 160963976
; 162011506
; 162176704
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D0R5RR
- Formula
- C10H11ClFN5O3
- Canonical SMILES
- C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N
- InChI
- 1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1
- InChIKey
- WDDPHFBMKLOVOX-AYQXTPAHSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.